Beyond this receptor-based classification, molecular intrinsic subtypes identified by the PAM50 gene expression signature further categorize breast cancers into luminal A (Lum A), luminal B (Lum B), HER2-enriched (HER2 +), basal-like, and normal-like subtypes [3, 4]. Here, ERBB2 is linked to breast cancer.